545376-10-1

Basic information

• Product Name: 2-[(1S)-3-HYDROXY-1-METHYLPROPYL]-1H-ISOINDOLE-1,3(2H)-DIONE
• Synonyms: 2-[(1S)-3-HYDROXY-1-METHYLPROPYL]-1H-ISOINDOLE-1,3(2H)-DIONE;(R)-2-(4-hydroxybutan-2-yl)isoindoline-1,3-dione;2-((S)-4-HYDROXYBUTAN-2-YL)ISOINDOLINE-1,3-DIONE
• CAS NO: 545376-10-1
• Molecular Formula: C12H13NO3
• Molecular Weight: 219.23652
• Mol File: 545376-10-1.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-[(1S)-3-HYDROXY-1-METHYLPROPYL]-1H-ISOINDOLE-1,3(2H)-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(1S)-3-HYDROXY-1-METHYLPROPYL]-1H-ISOINDOLE-1,3(2H)-DIONE(545376-10-1)
• EPA Substance Registry System: 2-[(1S)-3-HYDROXY-1-METHYLPROPYL]-1H-ISOINDOLE-1,3(2H)-DIONE(545376-10-1)

Safety Data

• Hazardous Substances Data: 545376-10-1(Hazardous Substances Data)

Usage

Chemical Class

Isoindole-1,3-diones

Molecular Weight

233.26 g/mol

Functional Groups

Hydroxy group (OH)
Methylpropyl group (CH3-CH(CH3)-CH2-)

Derivative

Derived from isoindole

Biological and Pharmacological Activities

Isoindole-1,3-diones are known for their potential biological and pharmacological activities.

Research Potential

Further research may be necessary to explore specific properties and potential uses.

Upstream product

• 245728-72-7 (R)-2-[3-(tert-butyldimethylsilyloxy)-1-methylpropyl]-1H-isoindole-1,3(2H)-dion 
• 85-44-9 phthalic anhydride 
• 61477-40-5 (R)-3-amino-1-butanol 
• 1218782-59-2 (S)-2-[3-(tert-butyldimethylsilyloxy)-1-methylpropyl]-1H-isoindole-1,3(2H)-dion 
• 61477-39-2 (+)-(S)-3-aminopropan-1-ol 
• 2867-59-6 2-aminobutanol 
• 4667-80-5 2-(1,3-dioxoisoindolin-2-yl)butan-4-al 

Relevant articles and documents

SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS

Disclosed herein are compounds that selectively bind an expanded transcribed repeat r(G4C2)exp, prevent sequestration of RNA-binding proteins, and inhibit translation of repeat associated non-ATG (RAN) translation responsible for generation of toxic dipeptide repeats underlying diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The compounds and their pharmaceutical compositions are useful in treating a disease or condition characterized by an expanded G4C2 repeat RNA (r(G4C2)exp), such as ALS and FTD.

Synthesis and in vitro sodium channel blocking activity evaluation of novel homochiral mexiletine analogs

New chiral mexiletine analogs were synthesized in their optically active forms and evaluated in vitro as use-dependent blockers of skeletal muscle sodium channels. Tests carried out on sodium currents of single muscle fibers of Rana esculenta demonstrated

2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION

The present invention has its object to provide a 2,3,4,5-tetrahydro-1H-1,5-benzodiazepine derivative represented with the Formula (1) , or the pharmaceutically acceptable salt, which is effective as a therapeutic and prophylactic agent for diabetes, diabetic nephropathy, or glomerulosclerosis.